Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The ...
For oncologists navigating the rapidly evolving landscape of renal cell carcinoma (RCC), the data presented at the 2026 ASCO ...
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The ...
With the advancement of imaging technologies, the application of 18 F-FDG PET/CT in the diagnosis and management of cervical cancer has garnered increasing attention. This article aims to review the ...
Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...
Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a ...
Petrylak, MD, of the Yale School of Medicine notes that bone health is a frequently underappreciated aspect of care for ...
The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Martin Gleave discussing how to optimize tissue biopsy ...
MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results